Hepatic lipase activity is increased in non-alcoholic fatty liver disease beyond insulin resistance
| Autor: | Diego Martín Lucero, Laura Schreier, Verónica Miksztowicz, Valeria Zago, Gabriela Berg, Eduardo Fassio, J.A. Sorda, Leonardo Cacciagiú, Graciela López, E. Gonzalez Ballerga |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
medicine.medical_specialty
Adiponectin Cholesterol business.industry Endocrinology Diabetes and Metabolism Insulin medicine.medical_treatment Fatty liver nutritional and metabolic diseases medicine.disease chemistry.chemical_compound Endocrinology Insulin resistance chemistry Internal medicine Internal Medicine medicine Hepatic lipase Steatosis business Lipoprotein |
| Zdroj: | Diabetes/Metabolism Research and Reviews. 28:535-541 |
| ISSN: | 1520-7552 |
| Popis: | Background and objective Hepatic lipase is a lipolytic enzyme mostly synthesized and localized at the surface of liver sinusoidal capillaries, which hydrolyses triglycerides and phospholipids of intermediate density, large low density (LDL) and high density lipoproteins. Hepatic lipase activity is increased in insulin resistant states. Non-alcoholic fatty liver disease (NAFLD) is characterized by insulin resistance. However, at present, no data are available regarding the behaviour of hepatic lipase with regard to the degree of hepatic steatosis. Our aim was to evaluate hepatic lipase activity in NAFLD patients and its relationship to the severity of hepatic steatosis. Design and patients We studied 48 patients with NAFLD (diagnosed by ultrasonography and confirmed by liver biopsy) and 30 controls. Steatosis was semi-quantitatively assessed and considered as mild or grade 1, moderate or grade 2 and severe or grade 3. Measurements: hepatic lipase activity, lipid and lipoprotein profile (including intermediate density lipoproteins and dense LDL), adiponectin, insulin, glucose and high sensitivity C-reactive protein were measured. Homeostasis model assessment for insulin resistance (HOMA) index was calculated. Results Patients with hepatic steatosis presented with higher hepatic lipase activity, HOMA and dense LDL and lower levels of adiponectin, high density lipoproteins, cholesterol and apoA-I. Hepatic lipase activity positively correlated significantly with the severity of hepatic steatosis. Hepatic lipase correlated with a more atherogenic profile and persisted higher in patients even after corrected for age, gender, body mass index, HOMA and adiponectin. Conclusion The higher hepatic lipase activity in NAFLD patients contributes to a more atherogenic profile linked to increased cardiovascular risk, beyond the insulin resistance and the reduction in adiponectin. Copyright © 2012 John Wiley & Sons, Ltd. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text